Ypsomed Holding AG (LON:0QLQ)

Market Cap	5.05B
Revenue (ttm)	655.71M
Net Income (ttm)	76.62M
Shares Out	n/a
EPS (ttm)	5.61
PE Ratio	65.90
Forward PE	29.12
Dividend	1.75 (0.43%)
Ex-Dividend Date	Jul 1, 2024

Volume	553
Average Volume	469
Open	411.50
Previous Close	413.64
Day's Range	410.50 - 414.00
52-Week Range	279.50 - 438.50
Beta	1.17
RSI	78.62
Earnings Date	May 21, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1984
• Employees: 2,644
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLQ

Financial Performance

In 2024, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.

Financial numbers in CHF